

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.67403374 |
| 2 | protein localization to endosome (GO:0036010) | 4.33752223 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.30313671 |
| 4 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.18686623 |
| 5 | protein carboxylation (GO:0018214) | 4.18686623 |
| 6 | urea metabolic process (GO:0019627) | 3.93383611 |
| 7 | urea cycle (GO:0000050) | 3.93383611 |
| 8 | pinocytosis (GO:0006907) | 3.89897695 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 3.85370381 |
| 10 | T-helper 1 type immune response (GO:0042088) | 3.68495129 |
| 11 | barbed-end actin filament capping (GO:0051016) | 3.68121812 |
| 12 | response to peptidoglycan (GO:0032494) | 3.67204915 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 3.64400195 |
| 14 | aldehyde catabolic process (GO:0046185) | 3.64328856 |
| 15 | positive regulation of extracellular matrix organization (GO:1903055) | 3.62705144 |
| 16 | tryptophan catabolic process (GO:0006569) | 3.61208554 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.61208554 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.61208554 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 3.56332899 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55736413 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.55736413 |
| 22 | amino sugar catabolic process (GO:0046348) | 3.53352761 |
| 23 | regulation of protein activation cascade (GO:2000257) | 3.46969419 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.46037069 |
| 25 | glycolipid catabolic process (GO:0019377) | 3.44950681 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.43198297 |
| 27 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.43143327 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.42303796 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.41369098 |
| 30 | myeloid dendritic cell differentiation (GO:0043011) | 3.40993930 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.40477646 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.37468599 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 3.36889802 |
| 34 | regulation of fibrinolysis (GO:0051917) | 3.36157644 |
| 35 | oligosaccharide catabolic process (GO:0009313) | 3.35132777 |
| 36 | plasma lipoprotein particle clearance (GO:0034381) | 3.33610449 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.32304792 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 3.32304792 |
| 39 | phospholipid homeostasis (GO:0055091) | 3.29932446 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29435358 |
| 41 | glycine metabolic process (GO:0006544) | 3.28768763 |
| 42 | regulation of complement activation (GO:0030449) | 3.27463061 |
| 43 | positive regulation of macrophage cytokine production (GO:0060907) | 3.22280355 |
| 44 | response to muramyl dipeptide (GO:0032495) | 3.21760723 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.20651569 |
| 46 | phospholipid efflux (GO:0033700) | 3.20218211 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.18352121 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 3.18352121 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.18148884 |
| 50 | fibrinolysis (GO:0042730) | 3.16656713 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.15891266 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.13643481 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09050099 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08887554 |
| 55 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.08020670 |
| 56 | stress fiber assembly (GO:0043149) | 3.06635717 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05856717 |
| 58 | apoptotic cell clearance (GO:0043277) | 3.05752759 |
| 59 | mannose metabolic process (GO:0006013) | 3.02248694 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02055375 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.01953571 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 2.98909799 |
| 63 | macromolecular complex remodeling (GO:0034367) | 2.98909799 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 2.98909799 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.97615395 |
| 66 | regulation of macrophage cytokine production (GO:0010935) | 2.96528719 |
| 67 | response to laminar fluid shear stress (GO:0034616) | 2.95160631 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 2.95102535 |
| 69 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94919075 |
| 70 | regulation of cholesterol storage (GO:0010885) | 2.93845915 |
| 71 | adhesion of symbiont to host (GO:0044406) | 2.92190248 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 2.92026887 |
| 73 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91152564 |
| 74 | bile acid biosynthetic process (GO:0006699) | 2.91126685 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 2.88745632 |
| 76 | cholesterol efflux (GO:0033344) | 2.87931830 |
| 77 | uronic acid metabolic process (GO:0006063) | 2.85499399 |
| 78 | glucuronate metabolic process (GO:0019585) | 2.85499399 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 2.83562759 |
| 80 | negative regulation of sterol transport (GO:0032372) | 2.82666104 |
| 81 | negative regulation of cholesterol transport (GO:0032375) | 2.82666104 |
| 82 | glyoxylate metabolic process (GO:0046487) | 2.82639769 |
| 83 | virion attachment to host cell (GO:0019062) | 2.82289603 |
| 84 | adhesion of symbiont to host cell (GO:0044650) | 2.82289603 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82236888 |
| 86 | arginine metabolic process (GO:0006525) | 2.81878140 |
| 87 | germinal center formation (GO:0002467) | 2.81695518 |
| 88 | ceramide catabolic process (GO:0046514) | 2.81495132 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 2.81458236 |
| 90 | cellular glucuronidation (GO:0052695) | 2.79471096 |
| 91 | sulfur amino acid catabolic process (GO:0000098) | 2.79182498 |
| 92 | peptide catabolic process (GO:0043171) | 2.78908704 |
| 93 | positive regulation of blood coagulation (GO:0030194) | 2.78273270 |
| 94 | positive regulation of hemostasis (GO:1900048) | 2.78273270 |
| 95 | lipoprotein metabolic process (GO:0042157) | 2.77099515 |
| 96 | cellular extravasation (GO:0045123) | 2.76622812 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.75571923 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.75441185 |
| 99 | NAD biosynthetic process (GO:0009435) | 2.75409002 |
| 100 | cellular response to arsenic-containing substance (GO:0071243) | 2.75247423 |
| 101 | serine family amino acid catabolic process (GO:0009071) | 2.74983749 |
| 102 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.73427823 |
| 103 | skin morphogenesis (GO:0043589) | 2.72614023 |
| 104 | modulation by symbiont of host cellular process (GO:0044068) | 2.71599799 |
| 105 | wound healing, spreading of epidermal cells (GO:0035313) | 2.70590296 |
| 106 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.69399259 |
| 107 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.69399259 |
| 108 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.69282833 |
| 109 | natural killer cell mediated immunity (GO:0002228) | 2.69282833 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.68762458 |
| 111 | regulation of early endosome to late endosome transport (GO:2000641) | 2.68638398 |
| 112 | response to thyroid hormone (GO:0097066) | 2.68083794 |
| 113 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.67957027 |
| 114 | regulation of macrophage chemotaxis (GO:0010758) | 2.67677949 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 2.66567925 |
| 116 | detection of external biotic stimulus (GO:0098581) | 2.66305901 |
| 117 | protein-lipid complex assembly (GO:0065005) | 2.65603071 |
| 118 | aromatic amino acid family metabolic process (GO:0009072) | 2.65352741 |
| 119 | regulation of superoxide anion generation (GO:0032928) | 2.65038592 |
| 120 | acylglycerol homeostasis (GO:0055090) | 2.63551145 |
| 121 | triglyceride homeostasis (GO:0070328) | 2.63551145 |
| 122 | membrane raft organization (GO:0031579) | 2.62293888 |
| 123 | positive regulation of coagulation (GO:0050820) | 2.62225805 |
| 124 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60302395 |
| 125 | homocysteine metabolic process (GO:0050667) | 2.59516766 |
| 126 | serine family amino acid metabolic process (GO:0009069) | 2.58530873 |
| 127 | cysteine metabolic process (GO:0006534) | 2.58108138 |
| 128 | dendritic cell differentiation (GO:0097028) | 2.57532089 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56954631 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.56954631 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56954631 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56954631 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56954631 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.56954631 |
| 135 | response to host (GO:0075136) | 2.56917033 |
| 136 | response to host defenses (GO:0052200) | 2.56917033 |
| 137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56917033 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56088494 |
| 139 | response to nitrosative stress (GO:0051409) | 2.56074227 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.55663247 |
| 141 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.55607061 |
| 142 | regulation of mononuclear cell migration (GO:0071675) | 2.54994015 |
| 143 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54684907 |
| 144 | protein retention in ER lumen (GO:0006621) | 2.54382526 |
| 145 | regulation of extracellular matrix organization (GO:1903053) | 2.53284037 |
| 146 | amine catabolic process (GO:0009310) | 2.53202390 |
| 147 | cellular biogenic amine catabolic process (GO:0042402) | 2.53202390 |
| 148 | acute-phase response (GO:0006953) | 2.53125218 |
| 149 | response to growth hormone (GO:0060416) | 2.52597664 |
| 150 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52281492 |
| 151 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51835345 |
| 152 | response to host immune response (GO:0052572) | 2.51835345 |
| 153 | bile acid metabolic process (GO:0008206) | 2.51777958 |
| 154 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.49202000 |
| 155 | regulation of monocyte differentiation (GO:0045655) | 2.48463233 |
| 156 | plasma lipoprotein particle organization (GO:0071827) | 2.48366044 |
| 157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48121473 |
| 158 | regulation of podosome assembly (GO:0071801) | 2.47850625 |
| 159 | osteoclast differentiation (GO:0030316) | 2.47591537 |
| 160 | N-acetylneuraminate metabolic process (GO:0006054) | 2.47381781 |
| 161 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.47232751 |
| 162 | cholesterol homeostasis (GO:0042632) | 2.46806833 |
| 163 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.45472178 |
| 164 | L-serine metabolic process (GO:0006563) | 2.45088239 |
| 165 | sterol homeostasis (GO:0055092) | 2.45019423 |
| 166 | bile acid and bile salt transport (GO:0015721) | 2.44509137 |
| 167 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.43458556 |
| 168 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.42411532 |
| 169 | cell adhesion mediated by integrin (GO:0033627) | 2.42349127 |
| 170 | growth hormone receptor signaling pathway (GO:0060396) | 2.41869077 |
| 171 | protein activation cascade (GO:0072376) | 2.41686023 |
| 172 | regulation of plasminogen activation (GO:0010755) | 2.41655546 |
| 173 | cytokine secretion (GO:0050663) | 2.41543536 |
| 174 | bone resorption (GO:0045453) | 2.41285112 |
| 175 | detection of other organism (GO:0098543) | 2.40212694 |
| 176 | cortical actin cytoskeleton organization (GO:0030866) | 2.39267324 |
| 177 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.34750082 |
| 178 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.34592580 |
| 179 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.33732339 |
| 180 | detection of biotic stimulus (GO:0009595) | 2.31361688 |
| 181 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.30989846 |
| 182 | membrane lipid catabolic process (GO:0046466) | 2.30523580 |
| 183 | cellular response to type I interferon (GO:0071357) | 2.30453448 |
| 184 | type I interferon signaling pathway (GO:0060337) | 2.30453448 |
| 185 | hyaluronan catabolic process (GO:0030214) | 2.30169831 |
| 186 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28050854 |
| 187 | response to type I interferon (GO:0034340) | 2.27904039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.03380216 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31899137 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06412622 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.95524151 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60191121 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.53232159 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45077400 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18780976 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.16714521 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.14551897 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99567608 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.89646085 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57269492 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45544710 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40577393 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.39156973 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36217861 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.33957228 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28811735 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25594933 |
| 21 | * MYC_22102868_ChIP-Seq_BL_Human | 2.24808544 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17422542 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15728335 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12818219 |
| 25 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.09877156 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08482700 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97331224 |
| 28 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96805275 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92991167 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92493969 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88432408 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84221448 |
| 33 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79178438 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76676203 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67065231 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66009602 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65009378 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63867683 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63610647 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62796652 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.62464638 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61362921 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55193939 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53649934 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53566235 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52661859 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.50946603 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50233412 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48302878 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44008965 |
| 51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41976941 |
| 52 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41023297 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40603729 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38220061 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37687642 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37261684 |
| 57 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.34954608 |
| 58 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34701279 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34581502 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32696225 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31608364 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30870059 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30756172 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30402657 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30292817 |
| 66 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.27801465 |
| 67 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26738829 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25716978 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24830028 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24411618 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.23997471 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23011646 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21157414 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19752823 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18360845 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17790066 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17326056 |
| 78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16473547 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16431827 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15472934 |
| 81 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13001915 |
| 82 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13001915 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12816468 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12293288 |
| 85 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10382554 |
| 86 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09974630 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09950397 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09765904 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09625889 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09514387 |
| 91 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.09155038 |
| 92 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08969797 |
| 93 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07681424 |
| 94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07370294 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07010151 |
| 96 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06976047 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04964699 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04840165 |
| 99 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.04829877 |
| 100 | * MAF_26560356_Chip-Seq_TH1_Human | 1.03842234 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03283204 |
| 102 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02455846 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.02451778 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01817762 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01613811 |
| 106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99417838 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98945041 |
| 108 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98025235 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97975901 |
| 110 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97936567 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97811500 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97113960 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96726418 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95972014 |
| 115 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95443827 |
| 116 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95033363 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94193457 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93859032 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93731660 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91997076 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91526759 |
| 122 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.91246355 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90545017 |
| 124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90348974 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87209935 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87186249 |
| 127 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86789660 |
| 128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86767320 |
| 129 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.86185892 |
| 130 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.85740750 |
| 131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85451943 |
| 132 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85339167 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84770572 |
| 134 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.84412362 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83898883 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83898883 |
| 137 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83227044 |
| 138 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.83035883 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82600445 |
| 140 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.81741113 |
| 141 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.81276755 |
| 142 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80858624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.09527851 |
| 2 | MP0005360_urolithiasis | 3.84027111 |
| 3 | MP0009840_abnormal_foam_cell | 3.12856502 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 2.96393796 |
| 5 | MP0005451_abnormal_body_composition | 2.82554647 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.81588743 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.73930351 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.73081032 |
| 9 | MP0005365_abnormal_bile_salt | 2.48843689 |
| 10 | MP0003252_abnormal_bile_duct | 2.41865089 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.40352088 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.38659255 |
| 13 | MP0000604_amyloidosis | 2.26903776 |
| 14 | MP0009053_abnormal_anal_canal | 2.23413461 |
| 15 | MP0003436_decreased_susceptibility_to | 2.21765016 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.12383737 |
| 17 | MP0003303_peritoneal_inflammation | 2.04937568 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.04639957 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.99993096 |
| 20 | MP0003724_increased_susceptibility_to | 1.95305386 |
| 21 | MP0005257_abnormal_intraocular_pressure | 1.91553194 |
| 22 | MP0003011_delayed_dark_adaptation | 1.79132379 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70439818 |
| 24 | MP0003075_altered_response_to | 1.66226009 |
| 25 | MP0008260_abnormal_autophagy | 1.65504267 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.62859164 |
| 27 | MP0009785_altered_susceptibility_to | 1.62631122 |
| 28 | MP0005503_abnormal_tendon_morphology | 1.57829935 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.55835670 |
| 30 | MP0003329_amyloid_beta_deposits | 1.54843454 |
| 31 | MP0009379_abnormal_foot_pigmentation | 1.54551689 |
| 32 | MP0002419_abnormal_innate_immunity | 1.52812697 |
| 33 | MP0001958_emphysema | 1.51039984 |
| 34 | MP0009764_decreased_sensitivity_to | 1.50092354 |
| 35 | MP0005083_abnormal_biliary_tract | 1.48428180 |
| 36 | MP0004510_myositis | 1.46564742 |
| 37 | MP0004947_skin_inflammation | 1.41472835 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.39197724 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.36662586 |
| 40 | MP0000858_altered_metastatic_potential | 1.35195684 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.33977812 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.32483982 |
| 43 | MP0006082_CNS_inflammation | 1.31776719 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.31760295 |
| 45 | MP0000609_abnormal_liver_physiology | 1.31746146 |
| 46 | MP0003186_abnormal_redox_activity | 1.30890874 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.29776725 |
| 48 | MP0003279_aneurysm | 1.29225564 |
| 49 | MP0005025_abnormal_response_to | 1.28613401 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.28162097 |
| 51 | MP0003448_altered_tumor_morphology | 1.27136652 |
| 52 | MP0004858_abnormal_nervous_system | 1.25077016 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.24516888 |
| 54 | MP0004233_abnormal_muscle_weight | 1.23128157 |
| 55 | MP0008469_abnormal_protein_level | 1.21603593 |
| 56 | MP0005023_abnormal_wound_healing | 1.20291932 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.19843168 |
| 58 | MP0005332_abnormal_amino_acid | 1.18778753 |
| 59 | MP0009278_abnormal_bone_marrow | 1.18691268 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.17991323 |
| 61 | MP0009697_abnormal_copulation | 1.17371846 |
| 62 | MP0001849_ear_inflammation | 1.12711417 |
| 63 | MP0000685_abnormal_immune_system | 1.12176203 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.11703315 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.09658906 |
| 66 | MP0005275_abnormal_skin_tensile | 1.09077584 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.08713475 |
| 68 | MP0009763_increased_sensitivity_to | 1.08026944 |
| 69 | MP0000598_abnormal_liver_morphology | 1.05605852 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.01884428 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.00066702 |
| 72 | MP0005000_abnormal_immune_tolerance | 0.99381539 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.98652859 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.97799624 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.97257120 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 0.97146506 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.96807355 |
| 78 | MP0005390_skeleton_phenotype | 0.96773511 |
| 79 | MP0001915_intracranial_hemorrhage | 0.96732188 |
| 80 | MP0002254_reproductive_system_inflammat | 0.96301291 |
| 81 | MP0005310_abnormal_salivary_gland | 0.96059259 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.95403033 |
| 83 | MP0003690_abnormal_glial_cell | 0.94319008 |
| 84 | MP0004272_abnormal_basement_membrane | 0.94289931 |
| 85 | MP0000716_abnormal_immune_system | 0.94127359 |
| 86 | MP0000920_abnormal_myelination | 0.94090688 |
| 87 | MP0002282_abnormal_trachea_morphology | 0.92937833 |
| 88 | MP0003091_abnormal_cell_migration | 0.92932638 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.92833399 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.92399862 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.92338021 |
| 92 | MP0003195_calcinosis | 0.91679170 |
| 93 | MP0005387_immune_system_phenotype | 0.90761413 |
| 94 | MP0001790_abnormal_immune_system | 0.90761413 |
| 95 | MP0000343_altered_response_to | 0.89737619 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.87912587 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.86573466 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.86291987 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.85375125 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.85140845 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.85140845 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.84258450 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.83941986 |
| 104 | MP0001853_heart_inflammation | 0.83224244 |
| 105 | MP0000371_diluted_coat_color | 0.82920999 |
| 106 | MP0003634_abnormal_glial_cell | 0.82495787 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.82113990 |
| 108 | MP0002723_abnormal_immune_serum | 0.81712935 |
| 109 | MP0003795_abnormal_bone_structure | 0.81297096 |
| 110 | MP0000249_abnormal_blood_vessel | 0.80918576 |
| 111 | MP0001800_abnormal_humoral_immune | 0.80886953 |
| 112 | MP0004883_abnormal_blood_vessel | 0.79989705 |
| 113 | MP0005165_increased_susceptibility_to | 0.78884073 |
| 114 | MP0002405_respiratory_system_inflammati | 0.78298319 |
| 115 | MP0002398_abnormal_bone_marrow | 0.77991521 |
| 116 | MP0001542_abnormal_bone_strength | 0.77819629 |
| 117 | MP0005621_abnormal_cell_physiology | 0.77230271 |
| 118 | MP0002429_abnormal_blood_cell | 0.76430610 |
| 119 | MP0002295_abnormal_pulmonary_circulatio | 0.76068412 |
| 120 | MP0005164_abnormal_response_to | 0.75640416 |
| 121 | MP0002166_altered_tumor_susceptibility | 0.74625205 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.74598719 |
| 123 | MP0005671_abnormal_response_to | 0.72163164 |
| 124 | MP0005508_abnormal_skeleton_morphology | 0.71691256 |
| 125 | MP0001819_abnormal_immune_cell | 0.71625830 |
| 126 | MP0006054_spinal_hemorrhage | 0.70273449 |
| 127 | MP0001243_abnormal_dermal_layer | 0.69734098 |
| 128 | MP0008874_decreased_physiological_sensi | 0.68767512 |
| 129 | MP0008007_abnormal_cellular_replicative | 0.68764878 |
| 130 | MP0002420_abnormal_adaptive_immunity | 0.68748768 |
| 131 | MP0000733_abnormal_muscle_development | 0.68485711 |
| 132 | MP0005166_decreased_susceptibility_to | 0.68281310 |
| 133 | MP0002060_abnormal_skin_morphology | 0.68046528 |
| 134 | MP0002933_joint_inflammation | 0.66823681 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.66113314 |
| 136 | MP0000627_abnormal_mammary_gland | 0.66104246 |
| 137 | MP0005197_abnormal_uvea_morphology | 0.66068743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.15916560 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.15916560 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.15916560 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.31922605 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.18579492 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.15913533 |
| 7 | Myocardial infarction (HP:0001658) | 4.13177393 |
| 8 | Complement deficiency (HP:0004431) | 4.04581554 |
| 9 | Xanthomatosis (HP:0000991) | 3.99168952 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.95489410 |
| 11 | Abnormality of complement system (HP:0005339) | 3.89973522 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.78787481 |
| 13 | Peritonitis (HP:0002586) | 3.76191004 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.74568882 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.70869736 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.63437247 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.61063471 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.59402159 |
| 19 | Joint hemorrhage (HP:0005261) | 3.58632763 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.54654203 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.36339908 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.35771465 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.25260478 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.21179240 |
| 25 | Glomerulonephritis (HP:0000099) | 3.15224170 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.12770850 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.11829124 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07236328 |
| 29 | Mucopolysacchariduria (HP:0008155) | 2.98345358 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.98345358 |
| 31 | Esophageal varix (HP:0002040) | 2.95191187 |
| 32 | Loss of speech (HP:0002371) | 2.91636372 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.89585504 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.89034440 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 2.88168848 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86673592 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86673592 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86673592 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.82338764 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.81862272 |
| 41 | Gingival bleeding (HP:0000225) | 2.70305032 |
| 42 | Hyperacusis (HP:0010780) | 2.69955412 |
| 43 | Nuclear cataract (HP:0100018) | 2.69289011 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.68101300 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.65073432 |
| 46 | Periodontitis (HP:0000704) | 2.57891875 |
| 47 | Biconcave vertebral bodies (HP:0004586) | 2.57088265 |
| 48 | Emphysema (HP:0002097) | 2.52115778 |
| 49 | Epidermoid cyst (HP:0200040) | 2.51383886 |
| 50 | Gingivitis (HP:0000230) | 2.50292115 |
| 51 | Abnormal hemoglobin (HP:0011902) | 2.50102358 |
| 52 | Upper motor neuron abnormality (HP:0002127) | 2.46398996 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.43187478 |
| 54 | Spondylolisthesis (HP:0003302) | 2.40752474 |
| 55 | Hyperglycinemia (HP:0002154) | 2.38226040 |
| 56 | Nephritis (HP:0000123) | 2.36898197 |
| 57 | Cellulitis (HP:0100658) | 2.36162135 |
| 58 | Purpura (HP:0000979) | 2.36130159 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.35273089 |
| 60 | Vascular tortuosity (HP:0004948) | 2.34854670 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.32823747 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.30783397 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.29483652 |
| 64 | Fat malabsorption (HP:0002630) | 2.28761248 |
| 65 | Mitral stenosis (HP:0001718) | 2.27945383 |
| 66 | Urticaria (HP:0001025) | 2.26339997 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.25842806 |
| 68 | Arterial tortuosity (HP:0005116) | 2.24802120 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.22897793 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.20033567 |
| 71 | Hyperammonemia (HP:0001987) | 2.19118552 |
| 72 | Disinhibition (HP:0000734) | 2.18575663 |
| 73 | Pathologic fracture (HP:0002756) | 2.18172123 |
| 74 | Natal tooth (HP:0000695) | 2.17264266 |
| 75 | Recurrent skin infections (HP:0001581) | 2.16392975 |
| 76 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16295853 |
| 77 | Vascular calcification (HP:0004934) | 2.15763736 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15334205 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.12875941 |
| 80 | Spinal cord lesions (HP:0100561) | 2.12407291 |
| 81 | Syringomyelia (HP:0003396) | 2.12407291 |
| 82 | Bladder diverticulum (HP:0000015) | 2.10798722 |
| 83 | Mitral valve prolapse (HP:0001634) | 2.08764625 |
| 84 | Soft skin (HP:0000977) | 2.08596563 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04849802 |
| 86 | Shallow orbits (HP:0000586) | 2.03913761 |
| 87 | Menorrhagia (HP:0000132) | 2.01477593 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.01253696 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.01253696 |
| 90 | Nausea (HP:0002018) | 2.00600037 |
| 91 | Neonatal short-limb short stature (HP:0008921) | 1.99543485 |
| 92 | Axonal loss (HP:0003447) | 1.98524404 |
| 93 | Restrictive lung disease (HP:0002091) | 1.98287890 |
| 94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.97123244 |
| 95 | Genu recurvatum (HP:0002816) | 1.96081958 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.93899343 |
| 97 | Cerebral aneurysm (HP:0004944) | 1.93488025 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 1.92984821 |
| 99 | Abnormal delivery (HP:0001787) | 1.92332811 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92126962 |
| 101 | Delayed CNS myelination (HP:0002188) | 1.90880437 |
| 102 | Skin nodule (HP:0200036) | 1.90083589 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 1.89793020 |
| 104 | Ovoid vertebral bodies (HP:0003300) | 1.89698243 |
| 105 | Osteolytic defects of the hand bones (HP:0009699) | 1.89691643 |
| 106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89691643 |
| 107 | Blue sclerae (HP:0000592) | 1.89226078 |
| 108 | Abnormality of the lumbar spine (HP:0100712) | 1.88210295 |
| 109 | Apathy (HP:0000741) | 1.87512068 |
| 110 | Dilatation of the ascending aorta (HP:0005111) | 1.86477511 |
| 111 | Amyloidosis (HP:0011034) | 1.85650693 |
| 112 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84638643 |
| 113 | Multiple lipomas (HP:0001012) | 1.84284943 |
| 114 | IgA deficiency (HP:0002720) | 1.83510497 |
| 115 | Spontaneous abortion (HP:0005268) | 1.83035556 |
| 116 | Diminished motivation (HP:0000745) | 1.82874650 |
| 117 | Cupped ribs (HP:0000887) | 1.82721394 |
| 118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82529415 |
| 119 | Thin bony cortex (HP:0002753) | 1.82005670 |
| 120 | Wormian bones (HP:0002645) | 1.81539530 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 1.81207030 |
| 122 | Ankle contracture (HP:0006466) | 1.79423624 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.78695832 |
| 124 | Mitral regurgitation (HP:0001653) | 1.78624188 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.78515208 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 1.77524966 |
| 127 | Acrocyanosis (HP:0001063) | 1.76883486 |
| 128 | Hematochezia (HP:0002573) | 1.76721535 |
| 129 | Flat acetabular roof (HP:0003180) | 1.76618188 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 1.76213041 |
| 131 | Abnormality of methionine metabolism (HP:0010901) | 1.75802348 |
| 132 | Hemorrhage of the eye (HP:0011885) | 1.74706419 |
| 133 | Basal ganglia calcification (HP:0002135) | 1.74686951 |
| 134 | Abnormality of the peritoneum (HP:0002585) | 1.74663823 |
| 135 | Cervical subluxation (HP:0003308) | 1.74555012 |
| 136 | Hepatocellular carcinoma (HP:0001402) | 1.74014910 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73489566 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.73489566 |
| 139 | Vasculitis (HP:0002633) | 1.73295861 |
| 140 | Colitis (HP:0002583) | 1.72188167 |
| 141 | Hyperglycinuria (HP:0003108) | 1.70930295 |
| 142 | Polycythemia (HP:0001901) | 1.70912171 |
| 143 | Recurrent viral infections (HP:0004429) | 1.69935190 |
| 144 | Aortic dissection (HP:0002647) | 1.68998637 |
| 145 | Short nail (HP:0001799) | 1.68024462 |
| 146 | Bone pain (HP:0002653) | 1.67955068 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.67827912 |
| 148 | Personality changes (HP:0000751) | 1.67292183 |
| 149 | Protuberant abdomen (HP:0001538) | 1.66301743 |
| 150 | Insomnia (HP:0100785) | 1.66177010 |
| 151 | Steatorrhea (HP:0002570) | 1.65554158 |
| 152 | Increased serum ferritin (HP:0003281) | 1.65425055 |
| 153 | Recurrent lower respiratory tract infections (HP:0002783) | 1.64424936 |
| 154 | Viral hepatitis (HP:0006562) | 1.64071359 |
| 155 | Achilles tendon contracture (HP:0001771) | 1.63503567 |
| 156 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.63467623 |
| 157 | Recurrent fungal infections (HP:0002841) | 1.63236142 |
| 158 | Aortic aneurysm (HP:0004942) | 1.62183553 |
| 159 | Pulmonary infiltrates (HP:0002113) | 1.61397691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.48344850 |
| 2 | NME2 | 3.55208379 |
| 3 | PRPF4B | 3.19553270 |
| 4 | BLK | 2.93407736 |
| 5 | IRAK3 | 2.70657655 |
| 6 | EIF2AK1 | 2.70446812 |
| 7 | ERN1 | 2.35523286 |
| 8 | PBK | 2.27949438 |
| 9 | RIPK4 | 2.27520358 |
| 10 | SMG1 | 2.19346331 |
| 11 | TBK1 | 2.14938255 |
| 12 | PIM2 | 2.14912999 |
| 13 | MAP3K14 | 2.08143515 |
| 14 | TRIB3 | 2.06969917 |
| 15 | MAP3K11 | 2.04383891 |
| 16 | IRAK4 | 2.02557902 |
| 17 | EPHA2 | 2.00141465 |
| 18 | RPS6KA4 | 1.98713295 |
| 19 | ICK | 1.81575831 |
| 20 | MAP3K13 | 1.76966211 |
| 21 | EPHA3 | 1.75709416 |
| 22 | TYK2 | 1.69583150 |
| 23 | TAOK2 | 1.64307925 |
| 24 | CDC42BPA | 1.64196602 |
| 25 | FLT3 | 1.58465276 |
| 26 | TESK2 | 1.57645690 |
| 27 | CDK12 | 1.56398739 |
| 28 | PKN2 | 1.55826270 |
| 29 | KDR | 1.50540938 |
| 30 | NUAK1 | 1.46699601 |
| 31 | EPHB2 | 1.46485927 |
| 32 | ABL2 | 1.44518612 |
| 33 | SIK1 | 1.42496665 |
| 34 | PTK6 | 1.38629031 |
| 35 | FGFR4 | 1.37964221 |
| 36 | PAK4 | 1.37194497 |
| 37 | ARAF | 1.33649133 |
| 38 | TGFBR2 | 1.32919692 |
| 39 | FGR | 1.32618545 |
| 40 | EEF2K | 1.30066093 |
| 41 | MAP4K1 | 1.29275346 |
| 42 | IKBKB | 1.28865938 |
| 43 | RIPK1 | 1.26509192 |
| 44 | TTN | 1.24976439 |
| 45 | CDK6 | 1.23650878 |
| 46 | DYRK1B | 1.21916252 |
| 47 | BCKDK | 1.15570722 |
| 48 | KIT | 1.12024588 |
| 49 | MAP3K10 | 1.11678355 |
| 50 | TAOK3 | 1.11221653 |
| 51 | JAK3 | 1.10082325 |
| 52 | TESK1 | 1.06988224 |
| 53 | MATK | 1.06517968 |
| 54 | IRAK1 | 1.03790685 |
| 55 | ZAP70 | 1.02130084 |
| 56 | * NEK9 | 1.00441393 |
| 57 | DAPK3 | 0.98343125 |
| 58 | MAP3K5 | 0.98277367 |
| 59 | MKNK2 | 0.98145515 |
| 60 | BUB1 | 0.96487902 |
| 61 | KSR2 | 0.94782505 |
| 62 | CHUK | 0.92059140 |
| 63 | FRK | 0.85401046 |
| 64 | MAP3K8 | 0.84604530 |
| 65 | EIF2AK2 | 0.83083628 |
| 66 | CSF1R | 0.83067052 |
| 67 | SIK2 | 0.81566417 |
| 68 | CSK | 0.81472850 |
| 69 | JAK1 | 0.81194956 |
| 70 | GRK7 | 0.79691131 |
| 71 | MAP3K3 | 0.79204221 |
| 72 | BMX | 0.78985792 |
| 73 | DDR2 | 0.78534336 |
| 74 | CAMK1G | 0.77577218 |
| 75 | IKBKE | 0.77331621 |
| 76 | PAK2 | 0.77179393 |
| 77 | MAPK11 | 0.76592102 |
| 78 | PDPK1 | 0.76493509 |
| 79 | LATS1 | 0.75156457 |
| 80 | SCYL2 | 0.75101382 |
| 81 | MST1R | 0.74490258 |
| 82 | CDK8 | 0.73842938 |
| 83 | MAP2K3 | 0.73195446 |
| 84 | LATS2 | 0.72093328 |
| 85 | SYK | 0.71388157 |
| 86 | PDGFRB | 0.70387309 |
| 87 | BMPR2 | 0.69969168 |
| 88 | MELK | 0.69308684 |
| 89 | MAP3K1 | 0.68491731 |
| 90 | ROCK2 | 0.68236555 |
| 91 | PRKD2 | 0.67212628 |
| 92 | RPS6KA2 | 0.66770117 |
| 93 | MAP2K2 | 0.66745560 |
| 94 | MAPK7 | 0.66610545 |
| 95 | ERBB2 | 0.66081629 |
| 96 | DYRK3 | 0.62318281 |
| 97 | MTOR | 0.61624211 |
| 98 | ERBB4 | 0.61143079 |
| 99 | MKNK1 | 0.60691162 |
| 100 | FER | 0.59740845 |
| 101 | PTK2 | 0.59263371 |
| 102 | JAK2 | 0.57904961 |
| 103 | MOS | 0.57870232 |
| 104 | LMTK2 | 0.57727425 |
| 105 | TAOK1 | 0.55243941 |
| 106 | PIM1 | 0.54454113 |
| 107 | LIMK1 | 0.53581806 |
| 108 | CDK9 | 0.51723122 |
| 109 | HCK | 0.51656153 |
| 110 | LYN | 0.50155917 |
| 111 | STK24 | 0.49725126 |
| 112 | CDK4 | 0.48451091 |
| 113 | YES1 | 0.47881295 |
| 114 | ABL1 | 0.47730621 |
| 115 | SRPK1 | 0.47677677 |
| 116 | STK4 | 0.47195432 |
| 117 | NTRK1 | 0.46516168 |
| 118 | PRKD3 | 0.45459689 |
| 119 | EGFR | 0.45256830 |
| 120 | MAPKAPK2 | 0.45251359 |
| 121 | PRKCD | 0.45195318 |
| 122 | TYRO3 | 0.44568763 |
| 123 | EPHB1 | 0.44121925 |
| 124 | TRPM7 | 0.43467530 |
| 125 | CAMKK2 | 0.43066047 |
| 126 | PDK1 | 0.43015611 |
| 127 | RPS6KC1 | 0.42927491 |
| 128 | RPS6KL1 | 0.42927491 |
| 129 | BTK | 0.42507481 |
| 130 | ERBB3 | 0.41513674 |
| 131 | IRAK2 | 0.41236439 |
| 132 | CDK7 | 0.40390643 |
| 133 | CAMK1D | 0.39212004 |
| 134 | STK10 | 0.39174196 |
| 135 | NLK | 0.38428357 |
| 136 | ILK | 0.38095383 |
| 137 | PIK3CG | 0.37133162 |
| 138 | FGFR3 | 0.36754344 |
| 139 | TEC | 0.36492736 |
| 140 | AURKB | 0.36355131 |
| 141 | HIPK2 | 0.36043235 |
| 142 | LRRK2 | 0.35982327 |
| 143 | SIK3 | 0.35968189 |
| 144 | STK38L | 0.35873047 |
| 145 | PDGFRA | 0.34238744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.24273731 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.95464158 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90665310 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84110993 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78316014 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51428422 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17975629 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.97913326 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94867179 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.94009986 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91346770 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86824858 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86746438 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69680882 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68105295 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.62340528 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61826860 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53814391 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52574359 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49432204 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48474835 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48354589 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44611770 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41004246 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38051891 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37826438 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37416534 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.30632240 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29652304 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29019370 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26941580 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26811770 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.22499833 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21481878 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21308453 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.20481263 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20188288 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.17792772 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17197755 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15104869 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13954134 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13212094 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12343443 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11348125 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10722770 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09307875 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09023354 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07252077 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06098486 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05634058 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 1.03993945 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.97991833 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97595018 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.96010151 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94842439 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94104093 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93973344 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92763213 |
| 59 | Ribosome_Homo sapiens_hsa03010 | 0.92690454 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91857070 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91595229 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90990610 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90935750 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89880640 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88870204 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88597623 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.85662151 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85179781 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83694171 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82765391 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82315362 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.80446352 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.78462451 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78031222 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.77366403 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74040120 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73712748 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73644218 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.73302234 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73176756 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.73019688 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72143605 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70978915 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.68416176 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68113689 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67935842 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67720229 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67444913 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66244557 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64937762 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64373086 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63687983 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63588630 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63435915 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63407328 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62802799 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62401026 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62001427 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61717886 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61204741 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60860626 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.60382469 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60139885 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.59755752 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.59598802 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59273791 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59168246 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59160478 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59133248 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59071132 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58972536 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58334775 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57830741 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57660388 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57184751 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55413712 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.55034077 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55002711 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54891995 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53792620 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53197933 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52482694 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51617251 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51301356 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51079691 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.51077944 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.50743920 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50543685 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49057209 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.48436798 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48211447 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47700747 |
| 133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47631472 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.47626820 |
| 135 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47579747 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47511232 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.46734031 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46257099 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46103243 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45669598 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45601015 |
| 142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45313209 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.45068393 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44930018 |
| 145 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43405620 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41949742 |
| 147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40489973 |
| 148 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39340308 |

